In contrast, in the NAFLD population, only 14.8% had higher AST levels relative to ALT levels, with 30.8% and 59.4% showing AST or ALT values of 30 IU/L or higher. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.